[144] General Motors Co SEC Filing

Rhea-AI Filing Summary

Form 144 filed for General Motors Co (GM) reports a proposed sale of 23,400 shares of common stock through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $1,417,806. The filing states the shares were acquired and will be sold on 09/26/2025 by exercise of stock options with cash payment. The issuer has 952,077,801 shares outstanding per the filing. The notice also discloses two prior 10b5-1 sales by the same person during the past three months: 14,667 shares on 08/27/2025 for $865,353 and 36,804 shares on 08/13/2025 for $2,027,969.84.

Positive

• Full disclosure of transaction details including broker (Morgan Stanley Smith Barney), exchange (NYSE), and aggregate market value ($1,417,806)
• Acquisition and sale date match (09/26/2025), indicating the filing covers an exercised option immediately followed by proposed sale
• Prior 10b5-1 sales disclosed with gross proceeds ($865,353 and $2,027,969.84), showing consistency with planned trading arrangements

Negative

• Insider proposed sale of 23,400 shares, which could be viewed negatively by some investors despite being a small fraction of outstanding shares
• Large realized proceeds in prior 10b5-1 sales (totaling $2,893,322.84) may attract investor attention to insider liquidity

Insights

Securities Analyst

TL;DR: Insider intends to sell 23,400 shares via exercise and brokered sale; prior 10b5-1 plan sales are disclosed.

The filing documents a proposed sale arising from an exercise of stock options executed and slated for sale on 09/26/2025. Execution through Morgan Stanley Smith Barney on the NYSE and explicit aggregate value ($1,417,806) provide clear marketable disposition details. Recent 10b5-1 sales on 08/13/2025 and 08/27/2025 are disclosed with gross proceeds, indicating prior planned dispositions by the same person. This is a routine insider liquidity event rather than a corporate operational disclosure; materiality to shareholders is limited to share count and cash proceeds disclosed.

Corporate Governance Expert

TL;DR: The filer attests no undisclosed material nonpublic information and documents a Rule 144 notice tied to exercised options.

The form includes the required attestation that the seller does not possess undisclosed material adverse information. The filing specifies the relationship to the issuer implicitly by showing option exercise as the acquisition method and identifies the broker and marketplace for the sale. Disclosure of recent 10b5-1 sales demonstrates compliance with planned trading protocols. From a governance perspective, the document meets procedural disclosure requirements; it contains no new governance actions or operational events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	23400	1417806.00	952077801	09/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/26/2025	Exercise of Stock Options	Issuer			23400	09/26/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOPHER HATTO 300 RENAISSANCE CENTER DETROIT MI 48265	Common	08/27/2025	14667	865353.00
10b5-1 Sales for CHRISTOPHER HATTO 300 RENAISSANCE CENTER DETROIT MI 48265	Common	08/13/2025	36804	2027969.84

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares is the GM insider proposing to sell?

The filing reports a proposed sale of 23,400 common shares, to be executed on 09/26/2025.

How much is the proposed sale worth according to the Form 144?

The aggregate market value disclosed is $1,417,806 for the 23,400 shares.

How were the 23,400 shares acquired?

The shares were acquired by exercise of stock options on 09/26/2025, with payment in cash.

Were there other recent insider sales by the same person?

Yes. The filing discloses two 10b5-1 sales in the past three months: 14,667 shares on 08/27/2025 for $865,353 and 36,804 shares on 08/13/2025 for $2,027,969.84.

Through which broker and exchange will the sale occur?

The sale is listed to occur via Morgan Stanley Smith Barney LLC on the NYSE.